| Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. | |
| | |
MedLine Citation:
|
PMID: 19808296 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Ventilatory efficiency, right ventricular (RV) function, and secondary pulmonary hypertension are each prognostic indicators in patients with heart failure due to left ventricular systolic dysfunction, but the relationships among these variables have not been comprehensively investigated. In this study, we hypothesized that inefficient ventilation during exercise, as defined by an abnormally steep relationship between ventilation and carbon dioxide output (Ve/Vco(2) slope), may be a marker of secondary pulmonary hypertension and RV dysfunction in heart failure. METHODS AND RESULTS: A cohort of patients with systolic heart failure (mean+/-SD age, 58+/-13 years; left ventricular ejection fraction, 0.27+/-0.05; peak oxygen uptake, 11.2+/-3.2 mL kg(-1) min(-1)) underwent incremental cardiopulmonary exercise testing with simultaneous hemodynamic monitoring and first-pass radionuclide ventriculography before and after 12 weeks of treatment with sildenafil, a selective pulmonary vasodilator, or placebo. Ve/Vco(2) slope was positively related to rest and exercise pulmonary vascular resistance (R=0.39 and R=0.60, respectively) and rest pulmonary capillary wedge pressure (R=0.49, P<0.005 for all) and weakly indirectly related to peak exercise RV ejection fraction (R=-0.29, P=0.03). Over the 12-week study period, Ve/Vco(2) slope fell 8+/-3% (P=0.02) with sildenafil and was unchanged with placebo. Changes in Ve/Vco(2) slope correlated with changes in exercise pulmonary vascular resistance (R=0.69, P<0.001) and rest and exercise RV ejection fraction (R=-0.58 and -0.40, respectively, both P<0.05). CONCLUSIONS: In patients with systolic heart failure and secondary pulmonary hypertension, ventilatory efficiency is closely related to RV function and pulmonary vascular tone during exercise. |
| | |
Authors:
|
Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran |
Related Documents
:
|
6648866 - Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during ... 20594816 - Resting respiratory variables and exercise capacity in adult patients with cystic fibro... 8680376 - Exercise-induced hypoxaemia in emphysematous type chronic obstructive pulmonary disease. 648506 - Influence of heavy weight carrying on the cardiorespiratory system during exercise. 22728946 - Time-dependent effects of treadmill exercise on aversive memory and cyclooxygenase path... 22977836 - Mechanisms of maladaptation to physical exercise in moscow schoolchildren. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Circulation. Heart failure Volume: 1 ISSN: 1941-3297 ISO Abbreviation: Circ Heart Fail Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: 2009-11-10 Revised Date: 2011-06-07 |
Medline Journal Info:
|
Nlm Unique ID: 101479941 Medline TA: Circ Heart Fail Country: United States |
Other Details:
|
Languages: eng Pagination: 227-33 Citation Subset: IM |
Affiliation:
|
Cardiology Division, Department of Medicine, and Pulmonary and Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. glewis@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Carbon Dioxide Cohort Studies Double-Blind Method Exercise Test Female Heart Failure / complications, diagnosis, physiopathology* Hemodynamics Humans Hypertension, Pulmonary / diagnosis, drug therapy, etiology, physiopathology* Male Middle Aged Muscle Tonus* Muscle, Smooth, Vascular / physiopathology* Piperazines / therapeutic use Pulmonary Circulation* Purines / therapeutic use Respiration* Sulfones / therapeutic use Vascular Resistance Vasodilator Agents / therapeutic use Ventricular Function, Right* Ventriculography, First-Pass |
| Grant Support | |
ID/Acronym/Agency:
|
HL 04021/HL/NHLBI NIH HHS; HL 091106/HL/NHLBI NIH HHS; K23 HL091106-01A1/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Piperazines; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 124-38-9/Carbon Dioxide; 139755-83-2/sildenafil |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Absence of exercise capacity improvement after exercise training program: a strong prognostic factor...
Next Document: Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: im...